2.4. The Combined Treatment of Heteronemin and Tetrac Downregulates ERK1/2 Phosphorylation and ERK1/2 Protein Levels in Human CRC Cells with Different KRAS Statuses. The gene discussed is KRAS; the disease is colorectal carcinoma.